We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.
1o9m
From Proteopedia
Revision as of 16:55, 28 September 2014 by OCA (Talk | contribs)
The ribosome is an important target for aminoglycoside antibiotics; however, the clinical effectiveness of aminoglycosides has diminished due to bacterial resistance mechanisms. Here we report the X-ray structure of a novel synthetic aminoglycoside bound to the A site of the ribosome, its target for manifestation of activity. The structure validates the in silico design paradigms for the antibiotic and reveals the molecular interactions made by this novel antibiotic in prokaryotes.
The complex of a designer antibiotic with a model aminoacyl site of the 30S ribosomal subunit revealed by X-ray crystallography.,Russell RJ, Murray JB, Lentzen G, Haddad J, Mobashery S J Am Chem Soc. 2003 Mar 26;125(12):3410-1. PMID:12643685[1]
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
References
↑ Russell RJ, Murray JB, Lentzen G, Haddad J, Mobashery S. The complex of a designer antibiotic with a model aminoacyl site of the 30S ribosomal subunit revealed by X-ray crystallography. J Am Chem Soc. 2003 Mar 26;125(12):3410-1. PMID:12643685 doi:http://dx.doi.org/10.1021/ja029736h
